New radiation strategy aims to tackle tough brain tumors
NCT ID NCT07353229
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-phase trial tests whether giving higher doses of radiation, guided by special PET/MRI scans, is safe for people with high-risk meningiomas (aggressive or recurrent brain tumors). About 24 adults will receive one of four radiation dose levels to find the highest dose that does not cause severe side effects. The goal is to improve tumor control while keeping risks manageable.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIGH RISK MENINGIOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Sidney Kimmel Cancer Center at Thomas Jefferson University
Philadelphia, Pennsylvania, 19107, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New radiation approach aims to stop brain tumor regrowth
- New combo therapy aims to stop returning brain tumors
- New hope for inoperable brain tumors: radioactive drug trial launches
- New hope for tough brain tumors: targeted radiation trial launches
- Immunotherapy meets radiation in fight against recurrent meningioma
- New drug combo targets tough brain tumors